Last reviewed · How we verify

NCT05995483: BreastSelfExam

Experimental Study With Pretest/Posttest Groups Which the Intervention Group Have the System Which Sends Reminder Notifications Directing Them to the Website Containing BSE Training Along With the Illustrations Created for the Practice Prepared by the Researcher on the Determined Ideal Day

Status unknown NA Last updated 16 August 2023
What this trial tests

NA trial testing Early Diagnosis on BSE in Breast Self-Examination in 76 participants. Status unknown.

Timeline
4 April 2023
Primary endpoint
4 September 2023
4 September 2023

Quick facts

Lead sponsorEastern Mediterranean University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment76
Start date4 April 2023
Primary completion4 September 2023
Estimated completion4 September 2023
Sites1 location across Cyprus

Drugs / interventions tested

Conditions studied

Sponsor

Eastern Mediterranean University

Who can join

Adults 18 to 30, female only, with Breast Self-Examination or Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

H0: Among the intervention and control groups of reminder notifications relating to self-examination H01: Average breast cancer fear score and H02: There is no difference in the average score of breast cancer health beliefs. H1: Among the intervention and control groups of reminder notifications relating to self-examination H11: Average breast cancer fear score H12: Breast cancer is different in terms of average score of health beliefs

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Breast Self-Examination

Currently open trials in the same condition.

Other Eastern Mediterranean University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05995483.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing